Innovation and brand development of Chinese medicine in China
 
 
 
Release date: 2013-11-28 

        To promote the continued and healthy development of Chinese traditional medicine enterprise in our country, promote transformation and upgrading of industries, and support brand enterprises and products development, build national brand to grow good environment, guarantee the people's drug is safe and effective, by the China association of traditional Chinese medicine combined Chinese medicine business association hosted a nice company, its "2012 China's TCM industry annual summit" on December 4, kicked off in guangzhou. 
 
        Summit as traditional Chinese medicine industry annual finale, every year to become the focus and hot spot of the industry, especially as the traditional Chinese medicine (TCM) industry to realize the development of traditional Chinese medicine "twelfth five-year" plan key year, organizers and industry enterprise carries from all sides look forward to, through the establishment of the innovation system of inheritance of traditional Chinese medicine, how to improve the technology of the contribution rate of traditional Chinese medicine industry, so as to improve the research and development and rational utilization of capacity, to strengthen the construction of Chinese traditional medicine industry innovation and brand, in order to improve the traditional Chinese medicine industry in the international market competitiveness, has become the path to the future development of Chinese medicine industry, is also the concern of the 2012 annual summit of the Chinese traditional medicine. 
 
        Through the research and development to promote brand value 
 
        From the development of traditional Chinese medicine "twelfth five-year" planning "in the us it is not hard to see, the government is the core of Chinese traditional medicine for the future development request" innovation "2 words, only through innovation can improve the competitiveness of the enterprises, and from the homogeneity of brand competition. 
 
        And the innovation of Chinese traditional medicine research and development efforts still need to get businesses further attention, especially in listed companies of all kinds of brand of TCM and modern traditional Chinese medicine. But Chinese medicine research and development of the situation is not optimistic in our country, especially compared with the international advanced level there are several gaps. From the aspects of capital investment, the American pharmaceutical enterprise r&d spending is far higher than that of other high and new technology industry, its average ratio to more than 15% of company sales revenue, and the r&d spending less than 5% of Chinese medicine enterprises in our country, some even less than 1%. At the same time, new drug research and development in our country generally borne by the state investment of scientific research institutes, enterprises owned or investment in research and development institutions is less, so that the link of traditional Chinese medicine research and development and production technology. In respect of pharmaceutical equipment, the gap also exists in China's and the world advanced level. By 2011, Japan has more than 200 Chinese prescription preparation production companies,, but its mechanization, automation and technology and management level is very high, especially in the purification of effective components of traditional Chinese medicine scientific research innovation and technical level is high, drug curative effect is stable and controllable quality. China's traditional Chinese medicine pharmaceutical equipment is now only at the level of developed countries in the 1970 s. Many Dan, pill, powder, tablet have different standard, unstable quality and so on. 
 
        In respect of development level of the backward is bound to affect the development of the enterprise brand, a lot of traditional Chinese medicine enterprise operators at through huge advertising to make up for the lack of itself on the r&d, however this kind of myopic behavior will only lead to short-term returns for the companies, when consumers return to rational enterprise into a state of dilemma again. Facing the government attaches great importance to the research and development, the traditional Chinese medicine (TCM) industry to the requirement during the twelfth five-year return calls for science and technology innovation, business operators should pay attention to their own research and development mode of innovation ability, the introduction of high-tech talent, truly through new technology and new varieties to achieve the breakthrough of the brand. 
 
        Correctly guide pricing, optimize the brand construction 
 
        And promote the development of corporate brand, in addition to the enterprise itself to promote research and development level to win the product competition, as the government and the society also has the corresponding responsibility, such as traditional Chinese medicine brand development should be timely introduction of pharmacoeconomics evaluation method, and evaluate the patients quality of life index. From 2011 annual summit, the reporter understands Chinese medicine industry, the government and related association is to promote to establish price evaluation standard in accordance with Chinese medicine characteristics, in order to objectively reflect the value of traditional Chinese medicine brand, guide the pricing of brand of traditional Chinese medicine. The evaluation of traditional Chinese medicine brand includes not only the clinical curative effect and safety evaluation, also including resource sustainable development, the traditional Chinese medicine standard, production management, quality of traditional Chinese medicine (TCM) and the evaluation index. Through the evaluation to the right for product pricing, to provide more healthy development environment for the brand, has become the government and society to support the development of traditional Chinese medicine brand in the future work. 
 
        In the research and development level of assurance and support of external factors, the brand construction of traditional Chinese medicine industry still exist many problems, and combining with the above problem, 2012 annual summit will invite Chinese medicine industry department in charge of authoritative experts, scholars, government officials and enterprise common interpretation, analysis and discussion; Summit in solving practical problems for the industry at the same time, also will convey to the relevant government department in charge of the correct enterprise voice, explore the traditional Chinese medicine industry rapid, healthy and sustainable development. Through the selection and promotion of traditional Chinese medicine (TCM) industry brand, to promote the healthy development of industry and the brand. 
 
        Source: pharmaceutical information network information center